Form D Explorer

Form D — Triton Therapeutics, Inc.

0002088152-25-000001 · filed 2025-10-23

Offering

Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $36,355,769
Total sold: $36,355,769
Minimum investment: $0
Investors: —
Sales commission: —
Finders' fees: —

Issuer

Name: Triton Therapeutics, Inc.
CIK: 2088152
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: 2025
Address: 700 FAIRFIELD AVENUE, SUITE 1
STAMFORD, CT 06902
Phone: 203-482-3123

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Paul Fonteyne · Executive Officer

Stamford, CT Find on LinkedIn ↗
Annie Mitsak · Director

Boston, MA Find on LinkedIn ↗
Timothy Shannon · Director

Stamford, CT Find on LinkedIn ↗
Elena Grigoryeva · Director

Princeton, NJ Find on LinkedIn ↗

View original on SEC EDGAR.